Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake

Go back to Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake
Regeneron (NASDAQ: REGN) Delayed: 810.06 +6.58 (0.82%)
Previous Close $803.48    52 Week High $592.36 
Open $801.76    52 Week Low $325.35 
Day High $813.18    P/E 212.61 
Day Low $795.73    EPS $3.81 
Volume 270,596